COMMUNIQUÉS West-GlobeNewswire

Axovant to Present at 36th Annual J.P. Morgan Healthcare Conference

05/01/2018 - 13:00

BASEL, Switzerland, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Axovant Sciences (NASDAQ: AXON ) today announced that its Chief Executive Officer David Hung, MD, will be presenting at the 36th Annual J.P. Morgan Healthcare [...]

Natus Appoints Leslie McDonnell as Vice President and General Manager of its Newborn Care Business Unit

05/01/2018 - 13:00

PLEASANTON, Calif., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) today announced it has named Leslie McDonnell as Vice President and General Manager of its Newborn Care Business Unit. Ms [...]

Zafgen Reports Strong Clinical Progress and Updates Outlook for 2018

05/01/2018 - 13:00

ZGN-1061 Phase 2 trial fully enrolled with type 2 diabetes patients; topline data expected mid-year Company returning to rare disorders with ZGN-1258; Prader-Willi syndrome expected as first indication Increased cash [...]

Dentsply Sirona to Present at the 36th Annual J.P. Morgan Healthcare Conference

05/01/2018 - 13:00

YORK, Pa., Jan. 05, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY ), The Dental Solutions Company™, today announced that the company will present at the 36 th Annual J.P. Morgan [...]

Chimerix Initiates AdAPT Study for Oral Brincidofovir and Advances IV Brincidofovir to Patient Studies

05/01/2018 - 13:00

- Pivotal AdAPT Study of Oral Brincidofovir for Adenovirus Now Enrolling - - No GI Adverse Effects for IV Brincidofovir 10 mg - - Announces First Antiviral Specific for Norovirus Now In Clinical Testing - DURHAM, N.C., [...]

OraSure Technologies to Present at the 36th Annual J.P. Morgan Healthcare Conference

05/01/2018 - 12:00

BETHLEHEM, Pa., Jan. 05, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, [...]

Ohr Pharmaceutical Announces Efficacy Results from the MAKO Study in Wet-AMD

05/01/2018 - 12:00

NEW YORK, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (NASDAQ: OHRP ), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today reported topline data from the MAKO [...]

BioCryst Advancing Potential Treatment for Rare and Severely Debilitating Fibrodysplasia Ossificans Progressiva

05/01/2018 - 12:00

RESEARCH TRIANGLE PARK, N.C., Jan. 05, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) announced today that it has advanced a program exploring activin receptor-like kinase-2 (ALK2) inhibitors [...]

TLC to Attend and Present at the 36th Annual JP Morgan Healthcare Forum

05/01/2018 - 11:00

TAIPEI, Taiwan, Jan. 05, 2018 (GLOBE NEWSWIRE) -- TLC (4152.TWO) today announced that it will be attending the 36 th annual JP Morgan Healthcare Conference in San Francisco on January 7-11, 2018. TLC President George [...]

Lundbeck enters research partnership on novel treatment of schizophrenia

05/01/2018 - 08:00

Valby, 2018-01-05 08:00 CET (GLOBE NEWSWIRE) -- H. Lundbeck A/S (Lundbeck) now adds another novel approach to its efforts to research and develop new and better treatments for schizophrenia. Forming a partnership with [...]

Motif Bio to participate in panel discussion at upcoming Cantor Antibiotics Summit

05/01/2018 - 08:00

NEW YORK, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM:MTFB) (NASDAQ: MTFB ), a clinical stage biopharmaceutical company specialising in developing novel antibiotics, announced today that the Company will [...]

Takeda announces its intention to acquire TiGenix

05/01/2018 - 07:31

PRESS RELEASE REGULATED INFORMATION Inside Information Communication in accordance with section 8, §1 of the Belgian Royal Decree of 27 April 2007 on public takeover bids Takeda announces its intention to acquire [...]

Takeda annonce son intention d'acquérir TiGenix

05/01/2018 - 07:31

COMMUNIQUÉ DE PRESSE INFORMATION RÉGLEMENTÉE INFORMATION PRIVILEGIEE Communication conformément à l'article 8, §1 de l'Arrêté Royal belge du 27 avril 2007 relatif aux offres publiques d'acquisition Takeda annonce son [...]

CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares

05/01/2018 - 01:03

ZUG, Switzerland and CAMBRIDGE, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP ), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, [...]

Micron Products, Inc. Announces New $9,500,000 Credit Facility

04/01/2018 - 23:41

FITCHBURG, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Micron Products, Inc. (“Micron”), a wholly owned subsidiary of Micron Solutions, Inc. (NYSE American:MICR), (“Micron Solutions”, collectively the “Company”) entered [...]

Veritas Pharma Provides Year End Update on Company’s Activities to Shareholders

04/01/2018 - 23:24

VANCOUVER, British Columbia, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) is pleased to provide an update to its prospective and current [...]

Obalon Schedules Fourth Quarter and Full Year 2017 Preliminary, Unaudited Revenue and Business Update Conference Call for January 5, 2018 at 8:30 a.m. Eastern Time

04/01/2018 - 23:15

SAN DIEGO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric [...]

MacroGenics to Present at the 36th Annual J.P. Morgan Healthcare Conference

04/01/2018 - 23:15

ROCKVILLE, MD, Jan. 04, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]

K2M Group Holdings, Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference

04/01/2018 - 22:40

LEESBURG, Va., Jan. 04, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]